US Patent Issued to ZOGENIX INTERNATIONAL on Sept. 15 for "Methods of treating Lennox-Gastaut Syndrome using fenfluramine" (California, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,137, issued on Sept. 15, was assigned to ZOGENIX INTERNATIONAL Ltd. (Berkshire, Great Britain).

"Methods of treating Lennox-Gastaut Syndrome using fenfluramine" was invented by Stephen J. Farr (Orinda, Calif.) and Bradley S. Galer (West Chester, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating and/or preventing symptoms of Lennox-Gastaut Syndrome (LGS) also known as Lennox Syndrome in a patient such as a patient previously diagnosed with Lennox Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Lennox Syndrome patients are treated at a preferred dose of less t...